We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amrize (AMRZ - Free Report) ) shares have been under considerable pressure as investors reassess the North American-focused building-materials company's earnings trajectory, margins, and execution.
Trading near a 52-week low of $36 a share, AMRZ is down 30% year to date after falling nearly 15% over the last month.
Adding to the bearish sentiment, Amrize was recently added to the Zacks Rank #5 (Strong Sell) list as earnings estimates have moved sharply lower.
That said, here are three key reasons investors may want to remain cautious on AMRZ.
Amrize has missed earnings expectations in each of the first two quarters of 2026.
Q1 adjusted earnings came in at a loss of $0.16 per share, compared with the Zacks EPS Consensus of -$0.14. Furthermore, Q2 adjusted EPS of $0.88 also missed the consensus estimate of $0.92.
More concerning has been profitability. Despite Q2 revenue rising 8%, Amrize's adjusted EBITDA margin slipped to 28.2% from 29%. Building Materials margins contracted 100 basis points, while Building Envelope margins fell 350 basis points. The latter segment includes roofing, insulation, and wall products designed to protect the exterior of buildings.
Image Source: Zacks Investment Research
2. Lower Guidance & Falling Earnings Estimates
Following Q2 results, Amrize revised its 2026 adjusted EBITDA outlook to $3.1-$3.2 billion from $3.25-$3.34 billion, citing oil-driven inflation in freight, diesel, and raw-material costs. The company expects those higher costs to remain a headwind to full-year earnings.
That weakening outlook has filtered directly into analyst earnings estimates, as FY26 and FY27 EPS projections have continued to decline in the last month and are now down over 7% in the last 60 days. Furthermore, current quarter and next quarter EPS revisions have fallen more than 13% and 56% in the last two months, respectively.
Image Source: Zacks Investment Research
3. Tariffs Add Another Risk for Amrize
Amrize's significant Canadian operations leave the company exposed to the broader fallout from U.S.-Canada trade tensions. Bank of America (BAC - Free Report) ) specifically cited tariffs as a risk to Canadian demand when lowering its outlook for the company.
To that point, the U.S. imposed 50% Section 338 tariffs on a wide range of Canadian goods this summer without a United States-Mexico-Canada Agreement(USMCA) exemption. Portland cement was initially affected, creating added uncertainty for Amrize's cross-border operations, although non-white Portland cement was subsequently removed from the tariff list effective Sept. 15.
Still, weaker Canadian demand and broader trade uncertainty represent additional concerns for a company already battling elevated costs and margin pressure.
Bottom Line
Amrize still has considerable exposure to long-term infrastructure and construction spending across North America, but its near-term earnings picture has deteriorated.
Two straight earnings misses, lower EBITDA expectations, margin pressure, analyst downgrades, and tariff-related uncertainty have contributed to AMRZ's steep decline. Recent leadership changes, including a new president for the Building Envelope segment, add another layer of execution uncertainty during an already challenging period.
View the Zacks #1 Rank List
Bear of the Day: Amrize (AMRZ)
Amrize (AMRZ - Free Report) ) shares have been under considerable pressure as investors reassess the North American-focused building-materials company's earnings trajectory, margins, and execution.
Trading near a 52-week low of $36 a share, AMRZ is down 30% year to date after falling nearly 15% over the last month.
Adding to the bearish sentiment, Amrize was recently added to the Zacks Rank #5 (Strong Sell) list as earnings estimates have moved sharply lower.
That said, here are three key reasons investors may want to remain cautious on AMRZ.
Image Source: Zacks Investment Research
1. Consecutive Earnings Misses & Weaker Profitability
Amrize has missed earnings expectations in each of the first two quarters of 2026.
Q1 adjusted earnings came in at a loss of $0.16 per share, compared with the Zacks EPS Consensus of -$0.14. Furthermore, Q2 adjusted EPS of $0.88 also missed the consensus estimate of $0.92.
More concerning has been profitability. Despite Q2 revenue rising 8%, Amrize's adjusted EBITDA margin slipped to 28.2% from 29%. Building Materials margins contracted 100 basis points, while Building Envelope margins fell 350 basis points. The latter segment includes roofing, insulation, and wall products designed to protect the exterior of buildings.
Image Source: Zacks Investment Research
2. Lower Guidance & Falling Earnings Estimates
Following Q2 results, Amrize revised its 2026 adjusted EBITDA outlook to $3.1-$3.2 billion from $3.25-$3.34 billion, citing oil-driven inflation in freight, diesel, and raw-material costs. The company expects those higher costs to remain a headwind to full-year earnings.
That weakening outlook has filtered directly into analyst earnings estimates, as FY26 and FY27 EPS projections have continued to decline in the last month and are now down over 7% in the last 60 days. Furthermore, current quarter and next quarter EPS revisions have fallen more than 13% and 56% in the last two months, respectively.
Image Source: Zacks Investment Research
3. Tariffs Add Another Risk for Amrize
Amrize's significant Canadian operations leave the company exposed to the broader fallout from U.S.-Canada trade tensions. Bank of America (BAC - Free Report) ) specifically cited tariffs as a risk to Canadian demand when lowering its outlook for the company.
To that point, the U.S. imposed 50% Section 338 tariffs on a wide range of Canadian goods this summer without a United States-Mexico-Canada Agreement (USMCA) exemption. Portland cement was initially affected, creating added uncertainty for Amrize's cross-border operations, although non-white Portland cement was subsequently removed from the tariff list effective Sept. 15.
Still, weaker Canadian demand and broader trade uncertainty represent additional concerns for a company already battling elevated costs and margin pressure.
Bottom Line
Amrize still has considerable exposure to long-term infrastructure and construction spending across North America, but its near-term earnings picture has deteriorated.
Two straight earnings misses, lower EBITDA expectations, margin pressure, analyst downgrades, and tariff-related uncertainty have contributed to AMRZ's steep decline. Recent leadership changes, including a new president for the Building Envelope segment, add another layer of execution uncertainty during an already challenging period.